2024-05-09 17:15:25 ET
GoodRx Holdings, Inc. (GDRX)
Q1 2024 Earnings Conference Call
May 09, 2024 08:00 AM ET
Company Participants
Whitney Notaro - VP, IR
Scott Wagner - Interim CEO
Karsten Voermann - CFO
Conference Call Participants
Michael Cherny - Leerink Partners
Jailendra Singh - Truist Securities
Stephanie Davis - Barclays
Daniel Grosslight - Citi
Lisa Gill - JP Morgan
Charles Rhyee - TD Cowen
Stan Bernstein - Wells Fargo Securities
Scott Schoenhaus - KeyBanc
Sean Dodge - RBC Capital Markets
John Ransom - RJF
John Park - Morgan Stanley
George Hill - Deutsche Bank
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the GoodRX First Quarter 2024 earnings call. At this time, a reminder, today's conference is being recorded.
I would now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin.
Whitney Notaro
Thank you, operator. Good morning, everyone. And welcome to GoodRX's earnings conference call for the first quarter of 2024. Joining me today are Scott Wagner, our Interim Chief Executive Officer, and Karsten Voermann, our Chief Financial Officer. Before we begin, I'd like to remind everyone that this call will contain forward-looking statements.
All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements, including without limitation statements regarding management's plans, strategies, goals and objectives, our market opportunity, our anticipated financial performance, underlying trends in our business, our value proposition, our potential for growth, our hybrid retail direct and PBM contracting approach, collaborations and partnerships with third parties.
Including our integrated savings program, anticipated impacts of the deprioritization of certain solutions under our pharma manufacturer solutions offering, and our cost savings initiative, expected impacts of the sunsetting of progress savings clubs, anticipated impacts of the change healthcare outage, our capital allocation priorities and the amount, timing and benefits of our share repurchase program.
These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors. These factors may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements....
Read the full article on Seeking Alpha
For further details see:
GoodRx Holdings, Inc. (GDRX) Q1 2024 Earnings Call Transcript